pentetic acid has been researched along with n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailly, T; Burgada, R; Ellender, M; Gray, SA; Hodgson, A; Leroux, YG; Moody, JC; Pearce, M; Stradling, GN; Wilson, I | 1 |
| Burgada, R; Durbin, PW; Gray, SA; Moody, JC; Pearce, MJ; Raymond, KN; Stradling, GN; Wilson, I | 1 |
| Bailly, T; Burgada, R; Durbin, PW; Leroux, Y; Masse, R; Poncy, JL; Rateau, G; Raymond, KN | 1 |
| Bailly, T; Burgada, R; Durbin, PW; Gray, SA; Leroux, Y; Moody, JC; Pearce, MJ; Raymond, KN; Stradling, GN; Wilson, I | 1 |
| Bailly, T; Burgada, R; Durbin, PW; Fritsch, P; Grillon, G; Metivier, H; Paquet, F; Poncy, JL; Raymond, KN | 1 |
| Bailly, T; Burgada, R; Fritsch, P; Grillon, G; Ramounet-Le Gall, B; Rateau, G | 1 |
| Fukuda, S | 1 |
1 review(s) available for pentetic acid and n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane
| Article | Year |
|---|---|
Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
Topics: Animals; Aza Compounds; Catechols; Chelating Agents; Deferiprone; Diphosphonates; Emergency Medicine; Humans; Iron Chelating Agents; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Uranium | 2005 |
6 other study(ies) available for pentetic acid and n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane
| Article | Year |
|---|---|
The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat: comparison with other siderophore analogues.
Topics: Administration, Inhalation; Americium; Amides; Animals; Aza Compounds; Body Burden; Female; Injections, Intravenous; Kidney; Liver; Pentetic Acid; Plutonium; Pyridones; Rats | 1992 |
Decorporation of thorium-228 from the rat by 3,4,3-LIHOPO and DTPA after simulated wound contamination.
Topics: Animals; Aza Compounds; Disease Models, Animal; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Kinetics; Ligands; Pentetic Acid; Pyridones; Rats; Thorium Compounds; Wound Healing | 1995 |
Efficacy of 3,4,3-LIHOPO for reducing the retention of 238Pu in rat after inhalation of the tributyl phosphate complex.
Topics: Administration, Inhalation; Animals; Aza Compounds; Decontamination; Lung; Male; Organometallic Compounds; Organophosphates; Organophosphorus Compounds; Pentetic Acid; Pyridones; Rats; Rats, Sprague-Dawley | 1993 |
Comparative efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat after simulated wound contamination as nitrates.
Topics: Americium; Animals; Aza Compounds; Decontamination; Female; Injections, Intramuscular; Injections, Subcutaneous; Pentetic Acid; Plutonium; Pyridones; Rats; Wounds and Injuries | 1993 |
Efficacy of 3,4,3-LIHOPO for enhancing the excretion of plutonium from rat after simulated wound contamination as a tributyl-n-phosphate complex.
Topics: Animals; Aza Compounds; Chelating Agents; Female; Organophosphates; Pentetic Acid; Plutonium; Pyridones; Rats; Rats, Sprague-Dawley; Wounds and Injuries | 1995 |
Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
Topics: Animals; Aza Compounds; Body Burden; Chelating Agents; Chelation Therapy; Decontamination; Dose-Response Relationship, Drug; Femur; Injections, Intravenous; Liver; Male; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Rats; Rats, Sprague-Dawley; Treatment Outcome; Uranium; Whole-Body Counting | 2003 |